Stoke Therapeutics, Inc. - Common Stock (STOK)
CUSIP: 86150R107
Q2 2020 13F Holders as of 30 Jun 2020
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 57,529,259
- Total 13F shares
- 34,945,268
- Share change
- +387,561
- Total reported value
- $824,517,432
- Price per share
- $23.83
- Number of holders
- 70
- Value change
- +$9,797,711
- Number of buys
- 26
- Number of sells
- 29
Quarterly Holders Quick Answers
What is CUSIP 86150R107?
CUSIP 86150R107 identifies STOK - Stoke Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 86150R107:
Top shareholders of STOK - Stoke Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ATP Life Science Ventures, L.P. |
13F
|
Company |
29%
|
16,786,713
|
$384,416,000 | — | 31 Mar 2020 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
6.2%
|
3,544,248
|
$81,163,000 | — | 31 Mar 2020 | |
| Redmile Group, LLC |
13F
|
Company |
3.8%
|
2,165,938
|
$49,600,000 | — | 31 Mar 2020 | |
| Cormorant Asset Management, LP |
13F
|
Company |
3%
|
1,709,765
|
$39,154,000 | — | 31 Mar 2020 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
2.9%
|
1,686,747
|
$38,627,000 | — | 31 Mar 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.4%
|
1,370,786
|
$31,391,000 | — | 31 Mar 2020 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
1.9%
|
1,119,963
|
$25,647,000 | — | 31 Mar 2020 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
1.4%
|
830,400
|
$19,016,000 | — | 31 Mar 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.4%
|
795,990
|
$18,229,000 | — | 31 Mar 2020 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.2%
|
671,978
|
$15,388,000 | — | 31 Mar 2020 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.92%
|
530,589
|
$12,150,000 | — | 31 Mar 2020 | |
| FMR LLC |
13F
|
Company |
0.81%
|
466,347
|
$10,679,000 | — | 31 Mar 2020 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.74%
|
427,522
|
$9,790,000 | — | 31 Mar 2020 | |
| STATE STREET CORP |
13F
|
Company |
0.51%
|
294,281
|
$6,739,000 | — | 31 Mar 2020 | |
| Artal Group S.A. |
13F
|
Company |
0.43%
|
250,000
|
$5,725,000 | — | 31 Mar 2020 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.35%
|
202,563
|
$4,639,000 | — | 31 Mar 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.35%
|
201,137
|
$4,607,000 | — | 31 Mar 2020 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.35%
|
200,000
|
$4,580,000 | — | 31 Mar 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.32%
|
185,856
|
$4,256,000 | — | 31 Mar 2020 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.32%
|
182,461
|
$4,178,000 | — | 31 Mar 2020 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.23%
|
131,180
|
$3,004,000 | — | 31 Mar 2020 | |
| Casdin Capital, LLC |
13F
|
Company |
0.21%
|
120,000
|
$2,748,000 | — | 31 Mar 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.2%
|
113,493
|
$2,599,000 | — | 31 Mar 2020 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.15%
|
86,110
|
$1,972,000 | — | 31 Mar 2020 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.12%
|
70,403
|
$1,613,000 | — | 31 Mar 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.1%
|
57,262
|
$1,311,000 | — | 31 Mar 2020 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.05%
|
27,254
|
$624,000 | — | 31 Mar 2020 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.04%
|
25,853
|
$592,000 | — | 31 Mar 2020 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.04%
|
22,279
|
$510,000 | — | 31 Mar 2020 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.04%
|
21,210
|
$486,000 | — | 31 Mar 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.04%
|
20,956
|
$480,000 | — | 31 Mar 2020 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.04%
|
20,218
|
$463,000 | — | 31 Mar 2020 | |
| Birchview Capital, LP |
13F
|
Company |
0.03%
|
20,000
|
$458,000 | — | 31 Mar 2020 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.03%
|
18,865
|
$432,000 | — | 31 Mar 2020 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.03%
|
17,300
|
$396,000 | — | 31 Mar 2020 | |
| Swiss National Bank |
13F
|
Company |
0.03%
|
15,600
|
$357,000 | — | 31 Mar 2020 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.03%
|
14,470
|
$331,000 | — | 31 Mar 2020 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.02%
|
14,100
|
$323,000 | — | 31 Mar 2020 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.02%
|
12,861
|
$295,000 | — | 31 Mar 2020 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.02%
|
10,603
|
$243,000 | — | 31 Mar 2020 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.02%
|
10,069
|
$231,000 | — | 31 Mar 2020 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.02%
|
9,600
|
$220,000 | — | 31 Mar 2020 | |
| MetLife Investment Management, LLC |
13F
|
Company |
0.01%
|
7,812
|
$178,895 | — | 31 Mar 2020 | |
| CITIGROUP INC |
13F
|
Company |
0.01%
|
7,192
|
$165,000 | — | 31 Mar 2020 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.01%
|
6,783
|
$155,000 | — | 31 Mar 2020 | |
| BARCLAYS PLC |
13F
|
Company |
0.01%
|
6,198
|
$142,000 | — | 31 Mar 2020 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.01%
|
5,910
|
$135,000 | — | 31 Mar 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
5,848
|
$134,000 | — | 31 Mar 2020 | |
| METROPOLITAN LIFE INSURANCE CO/NY |
13F
|
Company |
0.01%
|
5,525
|
$126,523 | — | 31 Mar 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
5,505
|
$126,000 | — | 31 Mar 2020 |
Institutional Holders of Stoke Therapeutics, Inc. - Common Stock (STOK) as of Q2 2020
As of 30 Jun 2020,
Stoke Therapeutics, Inc. - Common Stock (STOK) was held by
70 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,945,268 shares.
The largest 10 holders included
Apple Tree Partners IV, L.P., RTW INVESTMENTS, LP, Redmile Group, LLC, Cormorant Asset Management, LP, GILDER GAGNON HOWE & CO LLC, VANGUARD GROUP INC, BlackRock Inc., RA CAPITAL MANAGEMENT, L.P., FEDERATED HERMES, INC., and FMR LLC.
This page lists
70
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2020 vs Q1 2020 Across Filers
Q1 2020 holders
67
Q2 2020 holders
70
Holder diff
3
| Investor | Q1 2020 Shares | Q2 2020 Shares | Share Diff | Share Chg % | Q1 2020 Value $ | Q2 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.